1-20 of 232
kidney
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Associations of Kidney Tubular Biomarkers With Incident Macroalbuminuria and Sustained Low eGFR in DCCT/EDIC

Christine P. Limonte, Xiaoyu Gao, Ionut Bebu, Jesse C. Seegmiller, Amy B. Karger, Gayle M. Lorenzi, Mark Molitch, Harsha Karanchi, Bruce A. Perkins, Ian H. de Boer, DCCT, EDIC Research Group
Journal: Diabetes Care
Diabetes Care 2024;47(9):1539–1547
https://doi.org/10.2337/dc23-2196
Published: 14 March 2024
View article titled, Associations of Kidney Tubular Biomarkers With Incident Macroalbuminuria and Sustained Low eGFR in DCCT/EDIC
Open the PDF for Associations of Kidney Tubular Biomarkers With Incident Macroalbuminuria and Sustained Low eGFR in DCCT/EDIC in another window
Journal Articles

Impact of Canagliflozin on Kidney and Cardiovascular Outcomes by Type 2 Diabetes Duration: A Pooled Analysis of the CANVAS Program and CREDENCE Trials

Sheldon W. Tobe, Thomas A. Mavrakanas, Harpreet S. Bajaj, Adeera Levin, Navdeep Tangri, April Slee, Brendon L. Neuen, Vlado Perkovic, Kenneth W. Mahaffey, Wally Rapattoni, Fernando G. Ang
Journal: Diabetes Care
Diabetes Care 2024;47(3):501–507
https://doi.org/10.2337/dc23-1450
Published: 22 January 2024
View article titled, Impact of Canagliflozin on Kidney and Cardiovascular Outcomes by Type 2 Diabetes Duration: A Pooled Analysis of the CANVAS Program and CREDENCE Trials
Open the PDF for Impact of Canagliflozin on Kidney and Cardiovascular Outcomes by Type 2 Diabetes Duration: A Pooled Analysis of the CANVAS Program and CREDENCE Trials in another window
Journal Articles

Insulin Secretion, Sensitivity, and Kidney Function in Young Individuals With Type 2 Diabetes

Petter Bjornstad, Ye Ji Choi, Carson Platnick, Susan Gross, Phoom Narongkiatikhun, Isabella Melena, Lauryn Remmers, Madison Baca, Grant Schutte, Tyler Dobbs, Tim Vigers, Laura Pyle, Lynette Driscoll, Kalie Tommerdahl, Jessica Kendrick, Helen C. Looker, Allison Dart, David Cherney, Daniel H. van Raalte, Anand Srivastava, Luping Li, Pottumarthi Prasad, Pierre Saulnier, Robert G. Nelson, Richard J. Johnson, Kristen J. Nadeau, Bjornstad Lab, Nicholas Becker, Kyla Best, Carissa Birznieks, Michelle Bui, Diego Carrasco, Daniel Casillas, Maureen Flynn, Audrey Gruszcynski, Lucy Hall, Madeline Harbour, Melissa Leroux, Kelly Nash, Nhung Nguyen, Emily Sell, Callyn Rountree-Jablin
Journal: Diabetes Care
Diabetes Care 2024;47(3):409–417
https://doi.org/10.2337/dc23-1818
Published: 28 December 2023
View article titled, Insulin Secretion, Sensitivity, and Kidney Function in Young Individuals With Type 2 Diabetes
Open the PDF for Insulin Secretion, Sensitivity, and Kidney Function in Young Individuals With Type 2 Diabetes in another window
Journal Articles

Outcomes With Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Baseline Insulin Resistance

Thomas Ebert, Stefan D. Anker, Luis M. Ruilope, Paola Fioretto, Vivian Fonseca, Guillermo E. Umpierrez, Andreas L. Birkenfeld, Robert Lawatscheck, Charlie Scott, Katja Rohwedder, Peter Rossing, FIDELIO-DKD and FIGARO-DKD Investigators
Journal: Diabetes Care
Diabetes Care 2024;47(3):362–370
https://doi.org/10.2337/dc23-1420
Published: 27 December 2023
View article titled, Outcomes With Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Baseline Insulin Resistance
Open the PDF for Outcomes With Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Baseline Insulin Resistance in another window
Journal Articles

11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2024

American Diabetes Association Professional Practice Committee, Nuha A. ElSayed, Grazia Aleppo, Raveendhara R. Bannuru, Dennis Bruemmer, Billy S. Collins, Laya Ekhlaspour, Marisa E. Hilliard, Eric L. Johnson, Kamlesh Khunti, Ildiko Lingvay, Glenn Matfin, Rozalina G. McCoy, Mary Lou Perry, Scott J. Pilla, Sarit Polsky, Priya Prahalad, Richard E. Pratley, Alissa R. Segal, Jane Jeffrie Seley, Robert C. Stanton, Robert A. Gabbay
Journal: Diabetes Care
Diabetes Care 2024;47(Supplement_1):S219–S230
https://doi.org/10.2337/dc24-S011
Published: 11 December 2023
View article titled, 11. Chronic Kidney Disease and Risk Management: <em>Standards of Care in Diabetes—2024</em>
Open the PDF for 11. Chronic Kidney Disease and Risk Management: <em>Standards of Care in Diabetes—2024</em> in another window
Journal Articles

Association of Body Weight Time in Target Range With the Risk of Kidney Outcomes in Patients With Overweight/Obesity and Type 2 Diabetes Mellitus

Cheng Zu, Mengyi Liu, Xinyue Su, Yuanxiu Wei, Qiguo Meng, Chengzhang Liu, Ziliang Ye, Xiaoqin Gan, Yuanyuan Zhang, Panpan He, Chun Zhou, Fan Fan Hou, Xianhui Qin
Journal: Diabetes Care
Diabetes Care 2024;47(3):371–378
https://doi.org/10.2337/dc23-1727
Published: 11 December 2023
View article titled, Association of Body Weight Time in Target Range With the Risk of Kidney Outcomes in Patients With Overweight/Obesity and Type 2 Diabetes Mellitus
Open the PDF for Association of Body Weight Time in Target Range With the Risk of Kidney Outcomes in Patients With Overweight/Obesity and Type 2 Diabetes Mellitus in another window
Journal Articles

Diabetic Nephropathy: Update on Pillars of Therapy Slowing Progression

Sandra C. Naaman, George L. Bakris
Journal: Diabetes Care
Diabetes Care 2023;46(9):1574–1586
https://doi.org/10.2337/dci23-0030
Published: 25 August 2023
View article titled, Diabetic Nephropathy: Update on Pillars of Therapy Slowing Progression
Open the PDF for Diabetic Nephropathy: Update on Pillars of Therapy Slowing Progression in another window
Journal Articles

Risk Assessment of Kidney Disease Progression and Efficacy of SGLT2 Inhibition in Patients With Type 2 Diabetes

Filipe A. Moura, David D. Berg, Andrea Bellavia, Jamie P. Dwyer, Ofri Mosenzon, Benjamin M. Scirica, Stephen D. Wiviott, Deepak L. Bhatt, Itamar Raz, Mark W. Feinberg, Eugene Braunwald, David A. Morrow, Marc S. Sabatine
Journal: Diabetes Care
Diabetes Care 2023;46(10):1807–1815
https://doi.org/10.2337/dc23-0492
Published: 09 August 2023
View article titled, Risk Assessment of Kidney Disease Progression and Efficacy of SGLT2 Inhibition in Patients With Type 2 Diabetes
Open the PDF for Risk Assessment of Kidney Disease Progression and Efficacy of SGLT2 Inhibition in Patients With Type 2 Diabetes in another window
Journal Articles

Dulaglutide and Kidney Function–Related Outcomes in Type 2 Diabetes: A REWIND Post Hoc Analysis

Fady T. Botros, Hertzel C. Gerstein, Raleigh Malik, Claudia Nicolay, Anastasia Hoover, Ibrahim Turfanda, Helen M. Colhoun, Jonathan E. Shaw
Journal: Diabetes Care
Diabetes Care 2023;46(8):1524–1530
https://doi.org/10.2337/dc23-0231
Published: 21 June 2023
View article titled, Dulaglutide and Kidney Function–Related Outcomes in Type 2 Diabetes: A REWIND Post Hoc Analysis
Open the PDF for Dulaglutide and Kidney Function–Related Outcomes in Type 2 Diabetes: A REWIND Post Hoc Analysis in another window
Journal Articles

Cardiovascular and Renal Benefits of Novel Diabetes Drugs by Baseline Cardiovascular Risk: A Systematic Review, Meta-analysis, and Meta-regression

José M. Rodriguez-Valadez, Malak Tahsin, Kirsten E. Fleischmann, Umesh Masharani, Joseph Yeboah, Meyeon Park, Lihua Li, Ellerie Weber, Yan Li, Asem Berkalieva, Wendy Max, M.G. Myriam Hunink, Bart S. Ferket
Journal: Diabetes Care
Diabetes Care 2023;46(6):1300–1310
https://doi.org/10.2337/dc22-0772
Published: 23 May 2023
View article titled, Cardiovascular and Renal Benefits of Novel Diabetes Drugs by Baseline Cardiovascular Risk: A Systematic Review, Meta-analysis, and Meta-regression
Open the PDF for Cardiovascular and Renal Benefits of Novel Diabetes Drugs by Baseline Cardiovascular Risk: A Systematic Review, Meta-analysis, and Meta-regression in another window
Journal Articles

Comment on Tang et al. The Impact of Carbamylation and Anemia on HbA1c’s Association With Renal Outcomes in Patients With Diabetes and Chronic Kidney Disease. Diabetes Care 2023;46:130–137

Ninon Foussard, Alice Larroumet, Amandine Ferrière, Laurence Blanco, Kamel Mohammedi, Vincent Rigalleau
Journal: Diabetes Care
Diabetes Care 2023;46(5):e115
https://doi.org/10.2337/dc23-0070
Published: 26 April 2023
View article titled, Comment on Tang et al. The Impact of Carbamylation and Anemia on HbA<sub>1c</sub>’s Association With Renal Outcomes in Patients With Diabetes and Chronic Kidney Disease. Diabetes Care 2023;46:130–137
Open the PDF for Comment on Tang et al. The Impact of Carbamylation and Anemia on HbA<sub>1c</sub>’s Association With Renal Outcomes in Patients With Diabetes and Chronic Kidney Disease. Diabetes Care 2023;46:130–137 in another window
Journal Articles

Response to Comment on Tang et al. The Impact of Carbamylation and Anemia on HbA1c’s Association With Renal Outcomes in Patients With Diabetes and Chronic Kidney Disease. Diabetes Care 2023;46:130–137

Mengyao Tang, Sahir Kalim
Journal: Diabetes Care
Diabetes Care 2023;46(5):e116
https://doi.org/10.2337/dci23-0011
Published: 26 April 2023
View article titled, Response to Comment on Tang et al. The Impact of Carbamylation and Anemia on HbA<sub>1c</sub>’s Association With Renal Outcomes in Patients With Diabetes and Chronic Kidney Disease. Diabetes Care 2023;46:130–137
Open the PDF for Response to Comment on Tang et al. The Impact of Carbamylation and Anemia on HbA<sub>1c</sub>’s Association With Renal Outcomes in Patients With Diabetes and Chronic Kidney Disease. Diabetes Care 2023;46:130–137 in another window
Journal Articles

Glomerular Hyperfiltration Predicts Kidney Function Decline and Mortality in Type 1 and Type 2 Diabetes: A 21-Year Longitudinal Study

Diego Moriconi, Luca Sacchetta, Martina Chiriacò, Lorenzo Nesti, Giovanna Forotti, Andrea Natali, Anna Solini, Domenico Tricò
Journal: Diabetes Care
Diabetes Care 2023;46(4):845–853
https://doi.org/10.2337/dc22-2003
Published: 14 February 2023
View article titled, Glomerular Hyperfiltration Predicts Kidney Function Decline and Mortality in Type 1 and Type 2 Diabetes: A 21-Year Longitudinal Study
Open the PDF for Glomerular Hyperfiltration Predicts Kidney Function Decline and Mortality in Type 1 and Type 2 Diabetes: A 21-Year Longitudinal Study in another window
Journal Articles

Effects of Intensive Systolic Blood Pressure Lowering on End-Stage Kidney Disease and Kidney Function Decline in Adults With Type 2 Diabetes Mellitus and Cardiovascular Risk Factors: A Post Hoc Analysis of ACCORD-BP and SPRINT

Yahya M.K. Tawfik, Benjamin W. Van Tassell, Dave L. Dixon, William L. Baker, John Fanikos, Leo F. Buckley
Journal: Diabetes Care
Diabetes Care 2023;46(4):868–873
https://doi.org/10.2337/dc22-2040
Published: 14 February 2023
View article titled, Effects of Intensive Systolic Blood Pressure Lowering on End-Stage Kidney Disease and Kidney Function Decline in Adults With Type 2 Diabetes Mellitus and Cardiovascular Risk Factors: A Post Hoc Analysis of ACCORD-BP and SPRINT
Open the PDF for Effects of Intensive Systolic Blood Pressure Lowering on End-Stage Kidney Disease and Kidney Function Decline in Adults With Type 2 Diabetes Mellitus and Cardiovascular Risk Factors: A Post Hoc Analysis of ACCORD-BP and SPRINT in another window
Journal Articles

11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2023

Nuha A. ElSayed, Grazia Aleppo, Vanita R. Aroda, Raveendhara R. Bannuru, Florence M. Brown, Dennis Bruemmer, Billy S. Collins, Marisa E. Hilliard, Diana Isaacs, Eric L. Johnson, Scott Kahan, Kamlesh Khunti, Jose Leon, Sarah K. Lyons, Mary Lou Perry, Priya Prahalad, Richard E. Pratley, Jane Jeffrie Seley, Robert C. Stanton, Robert A. Gabbay
Journal: Diabetes Care
Diabetes Care 2023;46(Supplement_1):S191–S202
https://doi.org/10.2337/dc23-S011
Published: 12 December 2022
View article titled, 11. Chronic Kidney Disease and Risk Management: <em>Standards of Care in Diabetes—2023</em>
Open the PDF for 11. Chronic Kidney Disease and Risk Management: <em>Standards of Care in Diabetes—2023</em> in another window
Journal Articles

What Is the Best Medicine for Chronic Kidney Disease in Diabetes?

Andrea Giaccari
Journal: Diabetes Care
Diabetes Care 2022;45(12):2814–2816
https://doi.org/10.2337/dci22-0029
Published: 01 December 2022
View article titled, What Is the Best Medicine for Chronic Kidney Disease in Diabetes?
Open the PDF for What Is the Best Medicine for Chronic Kidney Disease in Diabetes? in another window
Journal Articles

The Impact of Carbamylation and Anemia on HbA1c’s Association With Renal Outcomes in Patients With Diabetes and Chronic Kidney Disease

Mengyao Tang, Anders Berg, Eugene P. Rhee, Andrew S. Allegretti, Sagar Nigwekar, S. Ananth Karumanchi, James P. Lash, Sahir Kalim
Journal: Diabetes Care
Diabetes Care 2023;46(1):130–137
https://doi.org/10.2337/dc22-1399
Published: 18 November 2022
View article titled, The Impact of Carbamylation and Anemia on HbA<sub>1c</sub>’s Association With Renal Outcomes in Patients With Diabetes and Chronic Kidney Disease
Open the PDF for The Impact of Carbamylation and Anemia on HbA<sub>1c</sub>’s Association With Renal Outcomes in Patients With Diabetes and Chronic Kidney Disease in another window
Journal Articles

Efficacy and Safety of Dapagliflozin by Baseline Insulin Regimen and Dose: Post Hoc Analyses From DECLARE-TIMI 58

Rena Pollack, Itamar Raz, Stephen D. Wiviott, Erica L. Goodrich, Sabina A. Murphy, Ilan Yanuv, Aliza Rozenberg, Ofri Mosenzon, Anna Maria Langkilde, Ingrid A.M. Gause-Nilsson, Deepak L. Bhatt, Lawrence A. Leiter, Darren K. McGuire, John P.H. Wilding, Marc S. Sabatine, Avivit Cahn
Journal: Diabetes Care
Diabetes Care 2023;46(1):156–164
https://doi.org/10.2337/dc22-1318
Published: 18 November 2022
View article titled, Efficacy and Safety of Dapagliflozin by Baseline Insulin Regimen and Dose: Post Hoc Analyses From DECLARE-TIMI 58
Open the PDF for Efficacy and Safety of Dapagliflozin by Baseline Insulin Regimen and Dose: Post Hoc Analyses From DECLARE-TIMI 58 in another window
Journal Articles

Long-term Outcomes With Islet-Alone and Islet-After-Kidney Transplantation for Type 1 Diabetes in the Clinical Islet Transplantation Consortium: The CIT-08 Study

Michael R. Rickels, Thomas L. Eggerman, Levent Bayman, Julie C. Qidwai, Rodolfo Alejandro, Nancy D. Bridges, Bernhard J. Hering, James F. Markmann, Peter A. Senior, Lawrence G. Hunsicker, on behalf of the Clinical Islet Transplantation Consortium
Journal: Diabetes Care
Diabetes Care 2022;45(12):2967–2975
https://doi.org/10.2337/dc21-2688
Published: 17 October 2022
View article titled, Long-term Outcomes With Islet-Alone and Islet-After-Kidney Transplantation for Type 1 Diabetes in the Clinical Islet Transplantation Consortium: The CIT-08 Study
Open the PDF for Long-term Outcomes With Islet-Alone and Islet-After-Kidney Transplantation for Type 1 Diabetes in the Clinical Islet Transplantation Consortium: The CIT-08 Study in another window
Journal Articles

Interleukin-6 and Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: New Insights From CANVAS

Akihiko Koshino, Meir Schechter, Taha Sen, Priya Vart, Brendon L. Neuen, Bruce Neal, Clare Arnott, Vlado Perkovic, Paul M. Ridker, Katherine R. Tuttle, Michael K. Hansen, Hiddo J.L. Heerspink
Journal: Diabetes Care
Diabetes Care 2022;45(11):2644–2652
https://doi.org/10.2337/dc22-0866
Published: 22 September 2022
View article titled, Interleukin-6 and Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: New Insights From CANVAS
Open the PDF for Interleukin-6 and Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: New Insights From CANVAS in another window